Concourse Financial Group Securities, Inc. Charles River Laboratories International, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $1.67 Billion
- Q4 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 735 shares of CRL stock, worth $85,083. This represents 0.01% of its overall portfolio holdings.
Number of Shares
735
Previous 973
24.46%
Holding current value
$85,083
Previous $191,000
29.32%
% of portfolio
0.01%
Previous 0.01%
Shares
26 transactions
Others Institutions Holding CRL
# of Institutions
699Shares Held
50.7MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$713 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$589 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$253 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$209 Million0.79% of portfolio
-
Allspring Global Investments Holdings, LLC1.77MShares$205 Million0.5% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $5.89B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...